Alkhurma Hemorrhagic Fever Virus RNA in Hyalomma rufipes Ticks Infesting Migratory Birds, Europe and Asia Minor.

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

Infectious Diseases

- Infectious Diseases PHGKB -

What's New

Last Posted: Apr 19, 2018

---

• Alkhurma Hemorrhagic Fever Virus RNA in Hyalomma rufipes Ticks Infesting Migratory Birds, Europe and Asia Minor.  
  Hoffman Tove et al. Emerging infectious diseases 2018 May (5) 879-882
• Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.  
  Zhu Dan Yan et al. Archives of virology 2018 May (5) 1253-1262
• Bayesian reconstruction of transmission within outbreaks using genomic variants. 
  De Maio Nicola et al. PLoS computational biology 2018 Apr (4) e1006117
• Biocuration: Distilling data into knowledge.  
  et al. PLoS biology 2018 Apr (4) e2002846
• Biogeography and environmental conditions shape bacteriophage-bacteria networks across the human microbiome.  
  Hannigan Geoffrey D et al. PLoS computational biology 2018 Apr (4) e1006099
• Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin.  
  Chai Jia Hui et al. PloS one 2018 (4) e0194648
• Distinctiveness and Similarities Between Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Cattle and the Community in Israel.  
  Lifshitz Ziv et al. Microbial drug resistance (Larchmont, N.Y.) 2018 Apr
• Epidemic Dynamics of Vibrio parahaemolyticus Illness in a Hotspot of Disease Emergence, Galicia, Spain.  
  Martinez-Urtaza Jaime et al. Emerging infectious diseases 2018 May (5) 852-859
• Genomic non-coding regions reveal hidden patterns of mumps virus circulation in Spain, 2005 to 2015.  
  Gavilán Ana M et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2018 Apr (15)
• Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.  
  Villena Rodolfo et al. Human vaccines & immunotherapeutics 2018 Apr 1-50